Efficacy of combined treatment for anaplastic thyroid carcinoma: Results of a multinstitutional retrospective analysis

International Journal of Surgery

Volumn 12, Issue S1, 2014, Pages S178-S182

  Conzo, Giovanni ^a   Polistena, Andrea ^b   Calò, Pietro Giorgio ^c   Bononi, Paolo ^d   Gambardella, Claudio ^a   Mauriello, Claudio ^a   Tartaglia, Ernesto ^a   Avenia, Stefano ^b   Sanguinetti, Alessandro ^b   Medas, Fabio ^c   de Toma, Giorgio ^d   Avenia, Nicola ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anaplastic thyroid carcinoma; Prognosis; Radiotherapy; Surgery; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; PACLITAXEL; SORAFENIB;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE CONTROL; ENDOPROSTHESIS; FEMALE; HUMAN; LOBECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SURGICAL PATIENT; THYROID CARCINOMA; THYROIDECTOMY; TRACHEOSTOMY; TUMOR VOLUME; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; ITALY; MORTALITY; MULTICENTER STUDY; PROCEDURES; SURVIVAL RATE; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; TREATMENT OUTCOME; TRENDS;

AGED; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84909987671     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.05.015     Document Type: Article

References (37)

1. Aschebrook-Kilfoy B., Ward M.H., Sabra M.M., Devesa S.S. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011, 21:125-134.
2. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper D.S., Doherty G.M., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19:1167-1214.
3. Misso C., Calzolari F., Puxeddu E., et al. Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome. G. Chir. 2008, 29(11-12):475-478.
4. Conzo G., Circelli L., Pasquali D., et al. Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 triple mutation of the RET proto-oncogene. Clin. Endocrinol. (Oxf) 2012, 77(6):934-936.
5. Rosato L., De Toma G., Bellantone R., et al. Diagnostic, therapeutic and healthcare management protocols in thyroid surgery: 3rd consensus conference of the Italian association of endocrine surgery units (U.E.C. CLUB). Minerva Chir. 2012, 67(5):365-379.
6. Lucchini R., Monacelli M., Santoprete S., et al. Differentiated thyroid tumors: surgical indications. G. Chir. 2013, 34(5-6):153-157.
7. Giuffrida D., Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann. Oncol. 2000, 11:1083-1089.
8. Quiros R.M., Ding H.G., Gattuso P., Prinz R.A., Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 Mutations. Cancer 2005, 103:2261-2268.
9. Nel C.J., van Heerden J.A., Goellner J.R., et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin. Proc. 1985, 60:51-58.
10. Derbel O., Limem S., Ségura-Ferlay C., et al. Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer 2011, 11:469.
11. Docimo G., Ruggiero R., Gubitosi A., et al. Ultrasound scalpel thyroidectomy: prospective randomized study. Ann. Ital. Chir. 2012, 83(6):491-496.
12. Cirocchi R., D'Ajello F., Trastulli S., et al. Meta-analysis of thyroidectomy with ultrasonic dissector versus conventional clamp and tie. World J. Surg. Oncol. 2010, 8:112.
13. Cirocchi R., Boselli C., Guarino S., et al. Total thyroidectomy with ultrasonic dissector for cancer: multicentric experience. World J. Surg. Oncol. 2012, 10:70.
14. Tan R.K., Finley R.K.I.I.I., Driscoll D., et al. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995, 17:41-47.
15. Junor E.J., Paul J., Reed N.S. Anaplastic thyroid carcinoma: ninety-one patients treated by surgery and radiotherapy. Eur. J. Surg. Oncol. 1992, 18:83-88.
16. Conzo G., Calò P.G., Sinisi A.A., et al. Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series. Surgery 2014, 155(6):998-1005.
17. Conzo G., Pasquali D., Bellastella G., et al. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine 2013, 44(2):419-425.
18. Conzo G., Docimo G., Pasquali D., et al. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. BMC Surg. 2013, 13(Suppl. 2):S3.
19. Conzo G., Docimo G., Mauriello C., et al. The current status of lymph node dissection in the treatment of papillary thyroid cancer. A literature review. Clin. Ter. 2013, 164(4):e343-e346.
20. Granata R., Locati L., Licitra L. Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literature. Curr. Opin. Oncol. 2013, 25(3):224-228.
21. Denaro N., Nigro C.L., Russi E.G., Merlano M.C. The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer. Onco Targets Ther. 2013, 9:1231-1241.
22. Swaak-Kragten A.T., de Wilt J.H., Schmitz P.I., Bontenbal M., Levendag P.C. Multimodality treatment for anaplastic thyroid carcinoma - treatment outcome in 75 patients. Radiother. Oncol. 2009, 92:100-104.
23. Pierie J.P., Muzikansky A., Gaz R.D., Faquin W.C., Ott M.J. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann. Surg. Oncol. 2002, 9:57-64.
24. Wang Y., Tsang R., Asa S., et al. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer 2006, 107:1786-1792.
25. De Besi P., Busnardo B., Toso S., et al. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J. Endocrinol. Invest 1991, 14:475-480.
26. Ain K.B. Management of undifferentiated thyroid cancer. Baillieres Best. Pract. Res. Clin. Endocrinol. Metab. 2000, 14:615-629.
27. Chen J., Tward J.D., Shrieve D.C., Hitchcock Y.J. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. Am. J. Clin. Oncol. 2008, 31:460-464.
28. Tennvall J., Lundell G., Wahlberg P., et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br. J. Cancer 2002, 86:1848-1853.
29. De Crevoisier R., Baudin E., Bachelot A., et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:1137-1143.
30. Haigh P.I., Ituarte P.H., Wu H.S., et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001, 91:2335-2342.
31. Levendag P.C., De Porre P.M., van Putten W.L. Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1993, 26:125-128.
32. Avenia N., Monacelli M., Sanguinetti A., et al. Therapeutic options in locally advanced thyroid carcinoma. Our experience. Ann. Ital. Chir. 2012, 83:481-485.
33. Brignardello E., Gallo M., Baldi I., et al. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur. J. Endocr. 2007, 156:425-430.
34. Antonelli A., Fallahi P., Ferrari S.M., et al. Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed. Pharmacother. 2008, 62:559-563.
35. Knauf J.A., Fagin J.A. Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Curr. Opin. Cell. Biol. 2009, 21:296-303.
36. Wiseman S.M., Masoudi H., Niblock P., et al. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann. Surg. Oncol. 2007, 14:719-729.
37. Baselga J., Arteaga C.L. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J. Clin. Oncol. 2005, 23:2445-2459.